CIK 0001709941 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
BioAge Labs, Inc.
Sign in to watch- Ticker
- BIOA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474721157
- Phone
- 510-806-1445
- Business address
- 5885 HOLLIS STREET, SUITE 370, EMERYVILLE, CA, 94608
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-02 | RUBIN PAUL D Chief Medical Officer | Option exercise 10b5-1 | +5,433 | $4.11 | $22K | 5,433 |
| 2026-01-02 | RUBIN PAUL D Chief Medical Officer | Option exercise 10b5-1 | +2,000 | $6.57 | $13K | 7,433 |
| 2026-01-02 | RUBIN PAUL D Chief Medical Officer | Sale 10b5-1 | −7,433 | $12.85 | $95K | 0 |
| 2026-01-02 | RUBIN PAUL D Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,433 | 16,303 | ||
| 2026-01-02 | RUBIN PAUL D Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,000 | 7,383 | ||
| 2025-12-09 | RUBIN PAUL D Chief Medical Officer | Option exercise 10b5-1 | +18,000 | $6.57 | $118K | 18,000 |
| 2025-12-09 | RUBIN PAUL D Chief Medical Officer | Sale 10b5-1 | −18,000 | $12.00 | $216K | 0 |
| 2025-12-09 | RUBIN PAUL D Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −18,000 | 9,383 | ||
| 2025-12-04 | RUBIN PAUL D Chief Medical Officer | Option exercise 10b5-1 | +68,897 | $4.11 | $283K | 68,897 |
| 2025-12-04 | RUBIN PAUL D Chief Medical Officer | Sale 10b5-1 | −68,897 | $10.19 | $702K | 0 |
| 2025-12-04 | RUBIN PAUL D Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −68,897 | 21,736 | ||
| 2025-08-07 | Pande Vijay Satyanand Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2025-06-05 | Hemrajani Rekha Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2025-06-05 | HEALY JAMES Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2025-06-05 | ENRIGHT PATRICK G Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2025-06-05 | Davidson Michael H. Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2025-06-05 | GARNIER JEAN PIERRE Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2025-02-18 | Morgen Eric Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2025-02-18 | RUBIN PAUL D Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2025-02-18 | Morgen Eric Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 |
Page 4 of 7 · 124 trades